Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

China Grand Pharmaceutical and Healthcare Holdings Ltd

0512
Current price
4.7 HKD 0 HKD (0.00%)
Last closed 4.74 HKD
ISIN BMG210A71016
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 16 374 516 674 HKD
Yield for 12 month +5.62 %
1Y
3Y
5Y
10Y
15Y
0512
21.11.2021 - 28.11.2021

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong. Address: The Center, Central, Hong Kong

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

45.16 HKD

P/E ratio

6.7681

Dividend Yield

5.51 %

Current Year

+10 543 152 346 HKD

Last Year

+9 574 601 438 HKD

Current Quarter

+6 055 024 973 HKD

Last Quarter

+4 545 951 753 HKD

Current Year

+6 532 469 141 HKD

Last Year

+5 959 144 641 HKD

Current Quarter

+3 595 934 687 HKD

Last Quarter

+2 659 049 510 HKD

Key Figures 0512

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 435 334 171 HKD
Operating Margin TTM 24.07 %
PE Ratio 6.7681
Return On Assets TTM 8.02 %
PEG Ratio
Return On Equity TTM 15.93 %
Wall Street Target Price 45.16 HKD
Revenue TTM 10 600 976 508 HKD
Book Value 4.49 HKD
Revenue Per Share TTM
Dividend Share 0.26 HKD
Quarterly Revenue Growth YOY 1 %
Dividend Yield 5.51 %
Gross Profit TTM 5 253 996 561 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 52.5 %
Profit Margin 22.75 %

Dividend Analytics 0512

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

21 %

Dividend History 0512

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.26
Ex Dividend Date 07.06.2024
Forward Annual Dividend Yield 5.51 %
Last Split Factor 737:733
Payout Ratio 37.74 %
Last Split Date 13.07.2018
Dividend Date

Stock Valuation 0512

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 6.7681
Forward PE
Enterprise Value Revenue 1.7708
Price Sales TTM 1.5446
Enterprise Value EBITDA 6.1908
Price Book MRQ 1.0515

Financials 0512

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0512

For 52 weeks

3.01 HKD 5.63 HKD
50 Day MA 4.64 HKD
Shares Short Prior Month
200 Day MA 4.35 HKD
Short Ratio
Shares Short
Short Percent